145 Aufrufe 145 0 Kommentare 0 Kommentare

    MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders

    MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders

    TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual and special meeting (the “Meeting”) of holders of common shares (“Shareholders”) held today.

    There were 389 Shareholders represented virtually or by proxy at the Meeting holding an aggregate of 130,357,074 common shares, representing 30.68% of MediPharm’s total issued and outstanding common shares as of the record date for the Meeting. As the Meeting was held virtually, all resolutions were passed by way of ballot. Complete voting results for each of the matters presented at the Meeting are provided below.

    Board Changes

    Following his re-election as a director, Keith Strachan was appointed Chair of the Board. Chris Taves, outgoing Chair, and Chris Halyk did not stand for re-election.

    “I am honoured to step into the role of Chair of the Board,” said Keith Strachan, Chair of the Board of MediPharm. “On behalf of the Board, I want to thank our Shareholders for their continued support, and to thank Chris Taves and Chris Halyk for their many contributions and years of service. As a co-founder and former President of MediPharm Labs, I have long believed in the Company’s potential, and I look forward to working with Greg, the management team and my fellow directors as we continue advancing the Company’s path to sustainable profitability across regulated medical cannabis markets.”

    Complete Voting Results from the Meeting

    1. Setting the Number of Directors at Five

    The special resolution to fix the number of directors of the Company at five (5) was approved. Voting results are as set out below:

    Votes For Votes Against
    # % # %
    125,319,545 96.136% 5,037,529 3.864%


    2. Board Size Authorizing Resolution

    The special resolution authorizing the directors of the Company to set the number of directors within the minimum and maximum provided in the Company’s articles was approved. Voting results are as set out below:

    Votes For Votes Against
    # % # %
    123,792,599 94.964% 6,564,474 5.036%

    Seite 1 von 4 





    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders TORONTO, June 17, 2026 (GLOBE NEWSWIRE) - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the …

    Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet.
    Profitieren Sie von unserem Alleinstellungsmerkmal als den zentralen verlagsunabhängigen Wissens-Hub für einen aktuellen und fundierten Zugang in die Börsen- und Wirtschaftswelt, um strategische Entscheidungen zu treffen.
    • ✅ Größte Finanz-Community Deutschlands
    • ✅ über 550.000 registrierte Nutzer
    • ✅ rund 2.000 Beiträge pro Tag
    • ✅ verlagsunabhängige Partner ARIVA, FinanzNachrichten und BörsenNews
    • ✅ Jederzeit einfach handeln beim SMARTBROKER+
    • ✅ mehr als 25 Jahre Marktpräsenz
    Aktien von A - Z: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    wallstreetONLINE bei X wallstreetONLINE bei Instagram wallstreetONLINE bei Facebook wallstreetONLINE bei Youtube wallstreetONLINE bei LinkedIn
    Unsere Apps: Apple App Store Icon Google Play Store Icon
    Wenn Sie Kursdaten, Widgets oder andere Finanzinformationen benötigen, hilft Ihnen ARIVA gerne. 

    Unsere User schätzen wallstreet-online.de: 4.8 von 5 Sternen ermittelt aus 285 Bewertungen bei www.kagels-trading.de
    Zeitverzögerung der Kursdaten: Deutsche Börsen +15 Min. NASDAQ +15 Min. NYSE +20 Min. AMEX +20 Min. Dow Jones +15 Min. Alle Angaben ohne Gewähr.
    Copyright © 1998-2026 Smartbroker Holding AG - Alle Rechte vorbehalten.
    Mit Unterstützung von: Ariva Smartbroker+
    Daten & Kurse von: TTMzero